Smoking Cessation, Weight Change, and Risk of Parkinson’s Disease: Analysis of National Cohort Data
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background and Purpose To determine whether the postcessation weight gain modifies the protective effect of smoking on the development of Parkinson’s disease (PD). Methods This nationwide cohort study included 3,908,687 Korean males aged ≥40 years who underwent at least 2 health checkups biennially between 2009 and 2015. They were grouped into current smokers; quitters with body mass index (BMI) increase, maintenance, and decrease; and never smokers. The occurrence of incident PD was tracked, and Cox proportional- hazard models were used to adjust for potential confounding factors. We also analyzed the impact of weight change regardless of smoking status in the study population. Results There were 6,871 incident PD cases observed during the 13,059,208 person-years of follow-up. The overall risk of PD was significantly lower in quitters than in never smokers [hazard ratio (HR)=0.78, 95% confidence interval (CI)=0.70–0.86]. The risk of PD was still lower in quitters with BMI increase (HR=0.80, 95% CI=0.65–0.98) and in those with BMI maintenance (HR=0.77, 95% CI=0.68–0.87). This tendency was also observed in quitters with BMI decrease (HR=0.76, 95% CI=0.55–1.06), although it was not as robust as in the other two groups. With respect to weight change alone, BMI increase (HR=1.10, 95% CI=1.02–1.18) but not BMI decrease (HR=1.06, 95% CI=0.98–1.14) significantly increased the PD risk compared to BMI maintenance. Conclusions Postcessation weight gain in males did not offset the protective impact of smoking on PD development, although overall weight gain predicted an increased risk of PD.
Abstract
Background and Purpose To determine whether the postcessation weight gain modifies the protective effect of smoking on the development of Parkinson’s disease (PD). Methods This nationwide cohort study included 3,908,687 Korean males aged ≥40 years who underwent at least 2 health checkups biennially between 2009 and 2015. They were grouped into current smokers; quitters with body mass index (BMI) increase, maintenance, and decrease; and never smokers. The occurrence of incident PD was tracked, and Cox proportional- hazard models were used to adjust for potential confounding factors. We also analyzed the impact of weight change regardless of smoking status in the study population. Results There were 6,871 incident PD cases observed during the 13,059,208 person-years of follow-up. The overall risk of PD was significantly lower in quitters than in never smokers [hazard ratio (HR)=0.78, 95% confidence interval (CI)=0.70–0.86]. The risk of PD was still lower in quitters with BMI increase (HR=0.80, 95% CI=0.65–0.98) and in those with BMI maintenance (HR=0.77, 95% CI=0.68–0.87). This tendency was also observed in quitters with BMI decrease (HR=0.76, 95% CI=0.55–1.06), although it was not as robust as in the other two groups. With respect to weight change alone, BMI increase (HR=1.10, 95% CI=1.02–1.18) but not BMI decrease (HR=1.06, 95% CI=0.98–1.14) significantly increased the PD risk compared to BMI maintenance. Conclusions Postcessation weight gain in males did not offset the protective impact of smoking on PD development, although overall weight gain predicted an increased risk of PD.
참고문헌 (25)
- Kalia LV, "Parkinson’s disease", Lancet, 386, pp.896~912 (2015)
- GBD 2016 Parkinson’s Disease Collaborators, "Global, regional, and national burden of Parkinson’s disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016", Lancet Neurol, 17, pp.939~953 (2018)
- Dorsey ER, "Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030", Neurology, 68, pp.384~386 (2007)
- Nam GE, "Metabolic syndrome and risk of Parkinson disease : a nationwide cohort study", PLoS Med, 15, pp.e1002640~ (2018)
- Ascherio A, "The epidemiology of Parkinson’s disease : risk factors and prevention", Lancet Neurol, 15, pp.1257~1272 (2016)
- Hernán MA, "Cigarette smoking and the incidence of Parkinson’s disease in two prospective studies", Ann Neurol, 50, pp.780~786 (2001)
- Thacker EL, "Temporal relationship between cigarette smoking and risk of Parkinson disease", Neurology, 68, pp.764~768 (2007)
- Chen H, "Smoking duration, intensity, and risk of Parkinson disease", Neurology, 74, pp.878~884 (2010)
- Kim R, "Sex differences in smoking, alcohol consumption, and risk of Parkinson’s disease : a nationwide cohort study", Parkinsonism Relat Disord, 71, pp.60~65 (2020)
- Li X, "Association between cigarette smoking and Parkinson’s disease : a meta-analysis", Arch Gerontol Geriatr, 61, pp.510~516 (2015)
- Korea Centers for Disease Control and Prevention, "2014 National Health Statistics", Ministry of Health and Welfare, ~ (2015)
- Bilano V, "Global trends and projections for tobacco use, 1990-2025 : an analysis of smoking indicators from the WHO Comprehensive Information Systems for Tobacco Control", Lancet, 385, pp.966~976 (2015)
- Harris KK, "Metabolic effects of smoking cessation", Nat Rev Endocrinol, 12, pp.299~308 (2016)
- Filozof C, "Smoking cessation and weight gain", Obes Rev, 5, pp.95~103 (2004)
- Nam GE, "BMI, weight change, and dementia risk in patients with new-onset type 2 diabetes : a nationwide cohort study", Diabetes Care, 42, pp.1217~1224 (2019)
- Park S, "Effect of late-life weight change on dementia incidence : a 10-year cohort study using claim data in Korea", BMJ Open, 9, pp.e021739~ (2019)
- Santiago JA, "Shared dysregulated pathways lead to Parkinson’s disease and diabetes", Trends Mol Med, 19, pp.176~186 (2013)
- Seong SC, "Data resource profile: the national health information database of the National Health Insurance Service in South Korea", Int J Epidemiol, 46, pp.799~800 (2017)
- Choi YJ, "The relationship between drinking alcohol and esophageal, gastric or colorectal cancer: a nationwide population-based cohort study of South Korea", PLoS One, 12, pp.e0185778~ (2017)
- Dehghani P, "Smokers and postcessation weight gain after acute coronary syndrome", J Am Heart Assoc, 6, pp.e004785~ (2017)
- 이승환, "Region-Based Analysis of Prevalence and Incidence of Parkinson’s Disease: Analysis of the National Sample Cohort in South Korea", Journal of Clinical Neurology, 14(4), pp.478~486 (2018), 대한신경과학회[DOI]
- Greenberg AS, "Obesity and the role of adipose tissue in inflammation and metabolism", Am J Clin Nutr, 83, pp.461S~465S (2006)
- Aviles-Olmos I, "Parkinson’s disease, insulin resistance and novel agents of neuroprotection", Brain, 136, pp.374~384 (2013)
- Hassanzadeh K, "Oxidative stress and neuroinflammation in the story of Parkinson’s disease: could targeting these pathways write a good ending?", J Cell Physiol, 234, pp.23~32 (2018)
- Searles Nielsen S, "A predictive model to identify Parkinson disease from administrative claims data", Neurology, 89, pp.1448~1456 (2017)